Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Sanofi US Services INC paid sponsored hires in similar roles2 certified filings for “Associate Director” (Regulatory Affairs Managers) in MA: $147k–$147k, median $147k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Sanofi US Services INC paid sponsored hires in similar roles
- 2 certified filings for “Associate Director” (Regulatory Affairs Managers) in MA: $147k–$147k, median $147k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Job title : Director, Access Strategy - aT1D
• Location: Morristown, NJ or Cambridge, MA (Hybrid - 3 Days a week in-office requirement)
About the Job
The Director, Access Strategy, aT1D will report to the Senior Director, aT1D and CV&M Access Strategy, US General Medicines. The role will serve as a strategic leader responsible for developing and implementing the short and long-term T1D access strategies across national and regional payers, institutions, and other key channel customers. This role requires the ability to translate complex market access concepts into clear, compelling value propositions while leading cross-functional initiatives and providing indirect leadership to field teams.
The successful candidate will leverage portfolio expertise and managed markets experience to build an integrated market access strategy that is aligned with brand objectives and global strategies. Excelling in this role requires sharp business acumen, the ability to turn customer insights into action and pinpoint priority customer segments, and outstanding communication and interpersonal skills to cultivate strong, productive relationships with both internal and external stakeholders.
In addition, the Director will define and execute various access strategies, pricing and contracting approaches, and supporting customer facing tools and resources. The role will also oversee management of budget and external vendors, including Agency of Record, to ensure effective execution and alignment with strategic priorities.
The incumbent will lead various cross-functional initiatives across diverse teams including Marketing, Market Access Shared Services, HEVA/RWE, Finance, Legal, Manufacturing and Logistics, and Field Sales.
Main Responsibilities:
• Develop short and long-term access strategies, including pricing and contracting recommendations, value propositions, messaging, and in-depth market research.
• Build comprehensive market access strategies and frameworks that integrate payer insights, competitive intelligence, and brand positioning to optimize patient access.
• Develop compelling value propositions and messaging frameworks that communicate brand’s clinical and economic value to diverse payer audiences.
• Represent the market access customer perspective within cross-functional commercialization teams, including Brand, USMA, HEOR/RWE, Medical, Market Access Shared Services, GTMC, Finance, Pricing, Communications, Policy/Advocacy, Legal, and Public Affairs.
• Partner with Medical, HEOR/RWE teams to inform evidence generation needs and translate clinical evidence into value proposition messaging and resources.
• Collaborate with global market access teams to align strategy development, incorporate US market insights, and support launch readiness.
• Monitor market dynamics, access challenges, competitive threats, and emerging opportunities to inform strategic planning and tactical execution.
• Create and deliver strategic presentations and communications to senior leadership and various cross-functional stakeholders as needed.
• Manage budget and external vendors, including Agency of Record to ensure timely delivery of key milestones and deliverables.
• Partner closely with V&A colleagues within BU and across the organization to share best practices, customer insights and emerging trends.
About You:
• BA/BS and 5+ years’ relevant professional experience including market access, health economics, pricing & reimbursement.
• Experience at local and/or international level w/ knowledge of US and Global market access & payer environment.
• Knowledge of disease market access is desirable, but other backgrounds in Specialty products and/or buy-and-bill products welcome.
• Proven experience in strategy de
Apply on employer site ↗